Newsmeme!
Discover News you didn't know existed
RISMEDIA, July 10, 2009-Price declines and low interest rates are motivating millions of home buyers to shop for bargains in the most affordable housing market in 28 years(1), yet at the same time only one-in-ten of today's home owners say they have delayed selling their home due to those same ...
Title: Menstrual Periods: Clues to Ovarian Cancer Category: Health News Created: 7/9/2009 Last Editorial Review: 7/9/2009
Patients who had first period before age 12 are at increased risk of death, study shows
THURSDAY, July 9 (HealthDay News) -- Among women with ovarian cancer, those who had their first menstrual period before the age of 12 and who had the most menstrual cycles over a lifetime are more likely to die of the cancer than those who had fewer ovulatory cycles, a new study shows.
Might help those with advanced disease buy time until transplant, study shows.
It's that time of the year again when church groups, summer camps, seasonal jobs, and corporate outings bring people not necessarily accustomed to full-size vans into them. While minivans are closely related mechanically to sedans and lower crossover vehicles and typically have top-notch safety ratings, full-size vans like the Ford Econoline ..
Allos Therapeutics, Inc. (Nasdaq: ALTH) announced the completion of patient enrollment in the Company's randomized Phase 2b clinical trial comparing pralatrexate to erlotinib (Tarceva®) in patients with Stage IIIB/IV non-small cell lung cancer (NSCLC) who are, or have been, cigarette smokers who have failed treatment with at least one prior platinum-based chemotherapy regimen.
CINCINNATI--OneCommand (www.onecommand.com) today announced dramatic successes for Toyota Dealers who have been utilizing new program features developed by the Company specifically to meet the needs of dealers in the recession economy.
Rae Kaytor is lobbying so Saskatchewan residents with incurable kidney cancer have access to drugs that will give them more time.
WESTMINSTER, Colo.----Allos Therapeutics, Inc. today announced the completion of patient enrollment in the Company's randomized Phase 2b clinical trial comparing pralatrexate to erlotinib in patients with Stage IIIB/IV non-small cell lung cancer who are, or have been, cigarette smokers who have failed treatment with at least one prior platinum-based chemotherapy regimen.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |